News about Clinical Trials

Orbis India sees need to handle preventive ophthalmic issues by incorporating eye screenings into primary healthcare

Orbis India sees the need to advance preventive ophthalmic issues by incorporating eye screenings into primary healthcare. This is because primary care is the first point of contact in the healthcare system for most people, making it an ideal setting for preventive interventions.

Clinical Trials | 16/06/2025 | By Darshana |  286

Novavax's Covid-19-influenza combination and stand-alone influenza vaccine candidates showed robust immune responses and were well tolerated in initial coh

Novavax, Inc. announced results of the initial cohort of its Covid-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV) phase 3 trial that showed both the CIC and flu vaccine candidates induced immune responses similar to licensed comparators Nuvaxovid and Fluzone HD, respectively.

Clinical Trials | 13/06/2025 | By Darshana |  158

Biscado enters India's beta-blocker therapy space, addressing the growing burden of heart disease

Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India

Clinical Trials | 11/06/2025 | By Darshana |  208

Adcendo Receives FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

Tiffany-01 is an ongoing first-in-human Phase I multicenter, open-label, dose escalation study of ADCE-T02 as a monotherapy in patients with advanced solid tumors.

Clinical Trials | 27/02/2025 | By Aishwarya |  653

Inventiva and Hepalys Pharma Initiate Clinical Development Program of Lanifibranor in Japan

The trial is conducted pursuant to the terms of the exclusive licensing agreement entered into in 2023 between Inventiva and Hepalys to develop and commercialize lanifibranor in Japan and South Korea.

Clinical Trials | 21/02/2025 | By Aishwarya |  730

AlzeCure Gets EU Grant for Phase 2 Clinical Trial of NeuroRestore ACD856

This funding will support AlzeCure’s planned Phase IIa study of NeuroRestore ACD856 in Alzheimer’s patients.

Clinical Trials | 19/02/2025 | By Aishwarya |  576

Selkirk Pharma Launches ClinFAST to Expedite Fill/Finish for Clinical Trials

Selkirk Pharma maintains an on-site inventory of ISO-sized vials, stoppers, filling assemblies, and excipients, reducing the lead time required for sourcing materials.

Clinical Trials | 14/02/2025 | By Aishwarya |  545

Philogen Completes Patient Enrollment of Phase III FIBROSARC Trial in STS

All ongoing Fibromun trials remain on track with their expected timelines.

Clinical Trials | 05/02/2025 | By Aishwarya |  1095

Exigent Research and ConcertAI to Integrate CARAai Precision Trial Solutions

The technology suite will be tailored and fully integrated to all Exigent sites and all EMRs and powered by the CARAai™ platform.

Clinical Trials | 04/02/2025 | By Aishwarya |  529

Renalys Pharma Completes Patient Enrollment for Phase III Trial of Sparsentan in Japan

In April 2024 Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.

Clinical Trials | 01/02/2025 | By Abha |  779